Alphatec HoldingsATEC
ATEC
About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Employees: 867
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
636% more call options, than puts
Call options by funds: $68.1M | Put options by funds: $9.26M
239% more capital invested
Capital invested by funds: $778M [Q4 2024] → $2.64B (+$1.86B) [Q1 2025]
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
26% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 34
21.18% more ownership
Funds ownership: 59.72% [Q4 2024] → 80.9% (+21.18%) [Q1 2025]
20% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 66
1% more funds holding
Funds holding: 227 [Q4 2024] → 230 (+3) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$15
36%
upside
Avg. target
$17
54%
upside
High target
$20
81%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Piper Sandler Matt O'Brien | 36%upside $15 | Overweight Reiterated | 2 May 2025 |
Needham David Saxon | 45%upside $16 | Buy Reiterated | 2 May 2025 |
HC Wainwright & Co. Sean Lee | 81%upside $20 | Buy Reiterated | 14 Apr 2025 |
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Matt Miksic - Barclays Mathew Blackman - Stifel Young Li - Jefferies Eric Anderson - TD Cowen David Saxon - Needham Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's First Quarter Financial Results.
Negative
Zacks Investment Research
1 month ago
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.34 per share a year ago.
Neutral
Business Wire
1 month ago
ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA.
Neutral
Business Wire
1 month ago
ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC's PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. “PTP Corpectomy represents a signific.
Positive
Seeking Alpha
3 months ago
Alphatec Holdings: Business Has Reached An Inflection Point - Buy The Dip
In recent years, Alphatec Holdings or "ATEC" has outperformed sales expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company continues to benefit from M&A-related disruptions at key competitors, which has created opportunities for ATEC to grab additional market share. Following years of elevated cash usage, the company managed to generate free cash flow in the final quarter of 2024.
Neutral
Business Wire
3 months ago
ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from t.
Neutral
Business Wire
3 months ago
ATEC Announces Proposed Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). ATEC also e.
Neutral
Seeking Alpha
3 months ago
Alphatec Holdings, Inc. (ATEC) Q4 2024 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Phillip Dantoin - Piper Sandler Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Jason Wittes - ROTH David Saxon - Needham Kallum Titchmarsh - Morgan Stanley Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Fourth Quarter Financial Results. We would like to remind everyone that participants on the call will make forward-looking statements.
Negative
Zacks Investment Research
3 months ago
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.37 per share a year ago.
Neutral
Business Wire
3 months ago
ATEC Reports Fourth Quarter and Full Year 2024 Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2024, and business highlights. Fourth Quarter and Full Year 2024 Financial Results Quarter Ended December 31, 2024 Year Ended December 31, 2024 Total revenue $177 million $612 million GAAP gross margin 69% 69% Non-GAAP gross margin 70% 70% Operating e.
Charts implemented using Lightweight Charts™